Efficacy and safety of ferric citrate for patients with chronic kidney disease:a Meta-analysis

Efficacy and safety of ferric citrate for patients with chronic kidney disease:a Meta-analysis

Objective To evaluate the efficacy and safety of ferric citrate for chronic kidney disease（CKD）patients with iron deficiency anemia and hyperphosphatemia. Methods Randomized controlled trials on the treatment of CKD with ferric citrate were retrieved from the databases of PubMed, Embase, MedLine, Co...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wan Hong-pin, Luo Min, Zhang Jian-bin
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Nephrology 2021-01-01
Series:	Linchuang shenzangbing zazhi
Subjects:	Ferric citrate Iron-based phosphorus binder Chronic kidney disease Anemia Hyperphosphatemia
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57903826&Fpath=home&index=0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety offerric citrate in treatment of hyperphosphatemia in patients with chronic kidney disease:a Meta-analysis
by: WANG Shan-shan, et al.
Published: (2020-01-01)

Electrochemical Performance of Pre-Modified Birch Biochar Monolith Supercapacitors by Ferric Chloride and Ferric Citrate
by: Ziyue Song, et al.
Published: (2025-01-01)

A Prospective Clinical Study of Ferric Citrate Hydrate for Chronic Heart Failure with Iron Deficiency Anemia
by: Akira Sezai, et al.
Published: (2025-04-01)

Ferric citrate hydrate improves transferrin saturation in patients with low levels of transferrin saturation undergoing hemodialysis
by: Keitaro Yokoyama, et al.
Published: (2024-12-01)

Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study
by: Aslan S, et al.
Published: (2025-06-01)

The Efficacy and Safety of Ferric Carboxymaltose in Heart Failure with Reduced Ejection Fraction and Iron Deficiency: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Inderbir Padda, et al.
Published: (2024-12-01)

Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01)

Effect of ferric carboxymaltose in the iron deficiency anemia patients undergoing cardiac surgery: A randomized clinical trial
by: Fateme Ramezani, et al.
Published: (2024-05-01)

Patient with Secondary Amyloidosis Due to Crohn’s Disease on Hemodialysis Effectively Treated with Ferric Carboxymaltose Injections: A Case Report and Literature Review
by: Masayo Ueno, et al.
Published: (2025-04-01)

Enhancing Catalytic Removal of <i>N</i>-Nitrosodimethylamine from Drinking Water Matrices with One-Step-Carbonized Ferric Ammonium Citrate
by: Jing Lv, et al.
Published: (2025-05-01)

The Effect of Ferric Carboxymaltose on Fibroblast Growth Factor 23 (FGF23) in Children with Iron Deficiency Anemia Due to Gastrointestinal Diseases
by: Maria Ntoumpara, et al.
Published: (2024-11-01)

Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers
by: Pablo E. Pergola, et al.
Published: (2025-01-01)

Comparative efficacy and tolerability of ferric pyrophosphate vs ferrous sulfate in pediatric iron deficiency anemia: a 6-month randomized controlled trial
by: Inderdeep Singh Kochar, et al.
Published: (2025-08-01)

Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01)

SODIUM CITRATE INFLUENCE ON FORMATION OF CEMENT STONE IN THE ALUMINOUS BINDER
by: S. N. Leonovich, et al.
Published: (2016-08-01)

Efficacy of tenapanor hydrochloride for hyperphosphatemia in hemodialysis patients: a single-center retrospective observational study
by: Motohiro Okamura, et al.
Published: (2025-07-01)

Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
by: Burhanuddin Sohail Rangwala, et al.
Published: (2024-12-01)

Therapeutic intervention with intravenous ferric carboxy-maltose: addressing iron deficiency among heart failure patients
by: Muneeza Ijaz, et al.
Published: (2024-11-01)

Efficacy and safety of intravenous ferric carboxymaltose in the treatment of Restless Legs Syndrome: a systematic review and meta-analysis
by: Ayesha Khan, et al.
Published: (2025-01-01)

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients
by: Qian Zeng, et al.
Published: (2023-12-01)

Process optimization for phosphorus removal with ferric salt by response surface methodology
by: ZHANG Meng, et al.
Published: (2012-09-01)

Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease
by: Wang Yu-han, et al.
Published: (2025-02-01)

Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease
by: Wang Yu-han, et al.
Published: (2025-02-01)

Serum Lactate Levels and Kinetics Predict Citrate Accumulation in Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy
by: Harmony Hau Man To, et al.
Published: (2025-08-01)

Impact of preoperative anemia and perioperative transfusion on short‐term outcomes in colorectal cancer surgery: The role of iron supplementation
by: Junpei Takashima, et al.
Published: (2025-03-01)

Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency
by: Anastasios Tsarouchas, et al.
Published: (2025-08-01)

Ferric Carboxymaltose in the Treatment of Anemia in Patients with Locally Advanced Colon Cancer
by: D. O. Kornev, et al.
Published: (2025-04-01)

Preparation and Properties of Ferric Chloride - starch Composite Flocculant
by: Jinxia ZHANG, et al.
Published: (2025-06-01)

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)

Arsenate and Arsenite Reaction Kinetics with Ferric Hydroxides Using Quantum Chemical Calculations
by: Cijin J. George, et al.
Published: (2018-10-01)

The Effect of Ferric Oxide on Candida albicans
by: Rima M.Y. Nasif, et al.
Published: (2025-07-01)

Effect of sodium citrate anticoagulation in Hemodiafiltration
by: BI Xiao-hong, et al.
Published: (2019-01-01)

Treatment of Citrate Accumulation Using Continuous «CalciumFree» Hemodiafiltration in a Patient with Acute Kidney Injury Undergoing Cardiac Surgery
by: S. V. Kolesnikov, et al.
Published: (2016-07-01)

Determining the effect of cadmium on embryogenesis in isolated administration and in combination with selenium and germanium citrates.
by: O. O. Nefyodov, et al.
Published: (2020-04-01)

Observation of the efficacy of long-term citrate anticoagulation in patients with maintenance hemodialysis
by: ZHUANG Feng, et al.
Published: (2020-01-01)

Effect of intravenous iron supply in patients with heart failure with reduced ejection fraction – a literature review
by: Katarzyna Dąbek, et al.
Published: (2024-12-01)

Treatment optimization for iron deficiency anemia in pregnant women as a resource to prevent perinatal complications
by: T. P. Zefirova, et al.
Published: (2024-05-01)

Morphology of embryonic liver under the influence of silver and gold citrates on a background of lead intoxication.
by: V. I. Harets, et al.
Published: (2016-05-01)

Morphology of embryonic liver under the influence of silver and gold citrates on a background of lead intoxication
by: Harets V.I., et al.
Published: (2016-05-01)

Hepcidin and iron metabolism disorders in patients with chronic kidney disease
by: Jelić Marija, et al.
Published: (2013-01-01)